CPBTD
REGN icon

Central Pacific Bank - Trust Division’s Regeneron Pharmaceuticals REGN Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.04M Buy
2,687
+1,275
+90% +$963K 0.21% 112
2026
Q2 		$880K Buy
1,412
+185
+15% +$126K 0.09% 216
2026
Q1 		$948K Sell
1,227
-170
-12% -$130K 0.12% 179
2025
Q4 		$1.08M Sell
1,397
-35
-2% -$23.8K 0.13% 159
2025
Q3 		$805K Buy
1,432
+275
+24% +$155K 0.1% 207
2025
Q2 		$607K Buy
1,157
+480
+71% +$268K 0.08% 250
2025
Q1 		$429K Sell
677
-50
-7% -$34.4K 0.06% 293
2024
Q4 		$518K Sell
727
-10
-1% -$8.39K 0.07% 257
2024
Q3 		$775K Sell
737
-5
-0.7% -$5.56K 0.1% 211
2024
Q2 		$780K Hold
742
– – 0.09% 228
2024
Q1 		$719K Buy
+742
New +$706K 0.09% 247

Other funds holding REGN

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
SBWIC
Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return
JC
Jacobs & Co San Francisco, California $1.16B AUM 34.03% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
VC
Veracity Capital Atlanta, Georgia $372M AUM 32.95% 1-Year Est. Return
CBT
Central Bank & Trust Lexington, Kentucky $701M AUM 26.18% 1-Year Est. Return

Central Pacific Bank - Trust Division's REGN Position: Q3 2026 in Review

Central Pacific Bank - Trust Division increased its Regeneron Pharmaceuticals (REGN) stake by 90% in Q3 2026, buying an estimated $963K and bringing the position to 2,687 shares worth $2.04M. The position accounts for 0.21% of the portfolio, ranked #112.

Central Pacific Bank - Trust Division first reported a position in REGN in Q1 2024 and has held it in 11 quarters since. 54 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Central Pacific Bank - Trust Division held 2,687 shares of Regeneron Pharmaceuticals worth $2.04M as of Q3 2026.
  • Central Pacific Bank - Trust Division bought 1,275 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $963K.
  • Regeneron Pharmaceuticals made up 0.21% of Central Pacific Bank - Trust Division's portfolio in Q3 2026, its #112 holding.
  • Central Pacific Bank - Trust Division first reported a position in Regeneron Pharmaceuticals in Q1 2024 and has held it in 11 quarters since.
  • 54 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.